|Project Title||Smoking Cessation Drugs and Cardiovascular Outcomes|
Sunday, January 15, 2012
Modular program-based one-time assessment of the risk of a composite cardiovascular outcome associated with new use of smoking cessation drugs, including varenicline and bupropion. Modular programs are adaptable standardized programs.
acute coronary occlusion without myocardial infarction
acute myocardial infarction (AMI)
intermediate coronary syndrome
Mini-Sentinel Distributed Database (MSDD)